#oncology
articles
Health
FDA Approves Pluvicto for Hormone-Sensitive Metastatic Prostate Cancer
The targeted radiation drug can now be used with hormone therapy in PSMA-positive metastatic prostate cancer after trial...
Health
Cancer Surgery Wait Times Rose Across Six Tumor Types From 2012 to 2023, Study Finds
A 2.7-million-patient National Cancer Database study found median time from diagnosis to first cancer treatment rose for...
Health
Ipsen’s Cabozantinib Offers New Option for Advanced Neuroendocrine Tumours After EU Approval
The targeted therapy, which blocks tumour growth, showed a 77% reduction in progression risk for pancreatic neuroendocri...
Companies
AstraZeneca and Bristol Myers in Talks Over Potential $400 Billion Pharma Merger
Report says the two drugmakers discussed a merger that would create a $400 billion oncology powerhouse, but the talks co...
Companies
AstraZeneca and Bristol Myers Squibb in Talks Over $400bn Pharma Merger
AstraZeneca and Bristol Myers Squibb are in merger talks that could create a nearly $400bn pharmaceutical giant, the Fin...
Health
Early-Stage KRAS Vaccine Trial Signals Potential for Pancreatic Cancer Prevention
A small trial of a KRAS-targeting vaccine in people at high risk of pancreatic cancer found it safe and able to spark a ...